Lumbal Erector Spinae Plane Block for Pain Management After Total Hip Arthroplasty
Ultrasound-Guided Lumbal Erector Spinae Plane Block on Postoperative Pain Management After Total Hip Arthroplasty
University Tunis El Manar
60 participants
Nov 1, 2025
INTERVENTIONAL
Conditions
Summary
The Erector Spinae Plane (ESP) block or spinal erector block was first described in September 2016 by a Canadian team. It's a block that was initially used for the treatment of chronic thoracic neuropathic pain. The ESP block is one of the inter-fascicular blocks and it's an easy-to-perform technique.In the literature, it has been reported that Lumbar ESPB provides effective analgesia after a hip surgery. The purpose of this prospective randomized study was to compare the analgesic effects of the ultrasound-guided lumbar Erector Spinae Plane block on postoperative pain management versus the multimodal analgesia after total hip arthroplasty.
Eligibility
Inclusion Criteria1
- primary total hip arthroplasty with lateral approach and under general anesthesia .
Exclusion Criteria9
- • Contraindication or refusal to regional anesthesia
- Contraindication to non-steroidal anti-inflammatory (NSAID's)
- Allergy to opioids
- Allergy to paracetamol
- Creatinine clearance \< 30ml/min
- Weight\<50 kg or \>100kg
- Psychiatric disorders and difficulty of communication
- Lower limb neurological deficit
- Patients undergoing bilateral or revision total hip replacement
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Lumbar ESP block performed after anesthesia induction. A low-frequency ultrasound probe will be placed longitudinally 2-3 cm lateral to the L4 transverse process. Erector spinae muscle will be visualized on the hyperechoic transverse process. The block needle (100 mm, 22G) will be inserted cranio-caudal direction and following confirmation of the correct position of the needle, between the erectorspinae muscle and the transverse process,30 ml of local anesthetic (0.25% bupivacaine/0.2% ropivacaine) will be administered for the block.
intravenous pain killers
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07240961